Legal & General Group
AMED

Legal & General Group’s Amedisys AMED Stock Holding History

Legal & General Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-72,297
Closed -$7.11M – 3408
2025
Q2 		$7.11M Buy
72,297
+2,890
+4% +$273K ﹤0.01% 1373
2025
Q1 		$6.43M Buy
69,407
+1,096
+2% +$101K ﹤0.01% 1393
2024
Q4 		$6.2M Buy
68,311
+285
+0.4% +$26.2K ﹤0.01% 1464
2024
Q3 		$6.57M Buy
68,026
+2,483
+4% +$242K ﹤0.01% 1441
2024
Q2 		$6.02M Sell
65,543
-2,684
-4% -$249K ﹤0.01% 1418
2024
Q1 		$6.29M Sell
68,227
-4,134
-6% -$387K ﹤0.01% 1402
2023
Q4 		$6.88M Sell
72,361
-3,731
-5% -$348K ﹤0.01% 1350
2023
Q3 		$7.11M Sell
76,092
-817
-1% -$75.5K ﹤0.01% 1250
2023
Q2 		$7.03M Buy
76,909
+4,017
+6% +$330K ﹤0.01% 1266
2023
Q1 		$5.36M Buy
72,892
+628
+0.9% +$54.3K ﹤0.01% 1379
2022
Q4 		$6.04M Buy
72,264
+670
+0.9% +$60.4K ﹤0.01% 1302
2022
Q3 		$6.93M Sell
71,594
-566
-0.8% -$67.5K ﹤0.01% 1213
2022
Q2 		$7.58M Sell
72,160
-5,209
-7% -$665K ﹤0.01% 1218
2022
Q1 		$13.3M Buy
77,369
+136
+0.2% +$20.3K ﹤0.01% 1032
2021
Q4 		$12.5M Sell
77,233
-3,657
-5% -$588K ﹤0.01% 1088
2021
Q3 		$12.1M Buy
80,890
+5,346
+7% +$1.11M ﹤0.01% 1076
2021
Q2 		$18.5M Sell
75,544
-9,512
-11% -$2.5M 0.01% 914
2021
Q1 		$22.5M Buy
85,056
+2,210
+3% +$623K 0.01% 834
2020
Q4 		$24.3M Sell
82,846
-2,857
-3% -$733K 0.01% 790
2020
Q3 		$20.3M Buy
85,703
+2,693
+3% +$612K 0.01% 784
2020
Q2 		$16.5M Buy
83,010
+7,276
+10% +$1.36M 0.01% 835
2020
Q1 		$13.9M Sell
75,734
-592
-0.8% -$105K 0.01% 818
2019
Q4 		$12.7M Buy
76,326
+2,716
+4% +$404K 0.01% 929
2019
Q3 		$9.64M Buy
73,610
+4,495
+7% +$585K 0.01% 995
2019
Q2 		$8.39M Buy
69,115
+36,042
+109% +$4.28M ﹤0.01% 1038
2019
Q1 		$4.08M Sell
33,073
-34,474
-51% -$4.33M ﹤0.01% 1322
2018
Q4 		$7.86M Buy
67,547
+661
+1% +$77.9K 0.01% 894
2018
Q3 		$8.3M Buy
66,886
+5,116
+8% +$565K 0.01% 934
2018
Q2 		$5.29M Buy
61,770
+1,672
+3% +$123K ﹤0.01% 1088
2018
Q1 		$3.62M Buy
60,098
+1,082
+2% +$61.6K ﹤0.01% 1284
2017
Q4 		$3.11M Sell
59,016
-9
-0% -$474 ﹤0.01% 1370
2017
Q3 		$3.3M Buy
59,025
+4,166
+8% +$220K ﹤0.01% 1279
2017
Q2 		$3.44M Buy
54,859
+2,972
+6% +$173K ﹤0.01% 1202
2017
Q1 		$2.65M Buy
51,887
+1,825
+4% +$87K ﹤0.01% 1299
2016
Q4 		$2.13M Buy
50,062
+22,893
+84% +$973K ﹤0.01% 1351
2016
Q3 		$1.29M Buy
27,169
+18,676
+220% +$932K ﹤0.01% 1287
2016
Q2 		$424K Hold
8,493
– – ﹤0.01% 1411
2016
Q1 		$408K Buy
8,493
+1,377
+19% +$53.1K ﹤0.01% 1396
2015
Q4 		$283K Hold
7,116
– – ﹤0.01% 1595
2015
Q3 		$266K Buy
7,116
+745
+12% +$31.4K ﹤0.01% 1565
2015
Q2 		$253K Buy
6,371
+865
+16% +$27K ﹤0.01% 1634
2015
Q1 		$147K Buy
5,506
+775
+16% +$21.9K ﹤0.01% 1809
2014
Q4 		$141K Sell
4,731
-345
-7% -$8.52K ﹤0.01% 1763
2014
Q3 		$103K Buy
+5,076
New +$97.9K ﹤0.01% 1862
2014
Q1 		– Sell
-34,787
Closed -$509K – 1306
2013
Q4 		$509K Buy
34,787
+1,529
+5% +$24.6K ﹤0.01% 1136
2013
Q3 		$573K Buy
+33,258
New +$493K ﹤0.01% 1090

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Legal & General Group's AMED Position: Q3 2025 in Review

Legal & General Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 72,297 shares — an estimated $7.11M sold.

Legal & General Group first reported a position in AMED in Q3 2013 and held it in 46 quarters. The position peaked at $24.3M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Legal & General Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Legal & General Group sold 72,297 Amedisys shares in Q3 2025, an estimated $7.11M.
  • Legal & General Group first reported a position in Amedisys in Q3 2013 and held it in 46 quarters.
  • Legal & General Group's Amedisys position peaked at $24.3M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Legal & General Group's 13F filing for Q3 2025, filed 13 Nov 2025.